arrow
A

Andrew R. Pettitt

university of liverpool
H指数:42
被引数:8,917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014–2022: An England-wide cohort study from the UNCOVER group

2014–2022年慢性淋巴细胞白血病的趋势与社会经济差异:UNCOVER小组的英格兰全国队列研究

2026-09-060
OAAI
A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network

阿卡巴鲁替尼与伊布替尼在慢性淋巴细胞白血病中相关心血管事件的比较分析:全球联邦网络的研究见解

2025-05-070
OA
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

以可测量的残留疾病为指导的慢性淋巴细胞白血病治疗

2024-01-2550
OA
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features
2022-11-0428
OAAI
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells

Kinobead分析揭示了原发性CLL细胞内BCR信号对治疗的重编程

2021-08-112
OAAI
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
2021-01-287
OAAI
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial
2020-02-135
OAAI
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL

评估双重mTORC1/2抑制剂vistusertib在复发,难治性DLBCL中的安全性和有效性的II期研究

2019-09-0920
OAAI
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
2019-08-2125
OAAI
The clinical importance of DNA methylation signatures in chronic lymphocytic leukemia patients treated with chemo-immunotherapy
2018-07-010
PRE